Clinical Research Directory

Inclusion Criteria: * has recurrent or metastatic solid cancer that has been proven histologically or cytologically and cannot be treated with surgery or radiotherapy for the purpos of complete remission * does not have a standard treatment that can be applied clinically according to the investigator's judgment * has an expected life expectancy of more than 3 months * adults aged 19 or older based on screening day * ECOG performance status : 0\~1 Exclusion Criteria: * Has a history of hypersensitivity or other contraindications to rhGM-CSF and Montanide ISA 51 VG * Has a history of other primary malignant tumor * Has autoimmune diseases or inflammatory diseases * Has a history of active primary immunodeficiency disease * Has active infection including tuberculosis, hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection * Is pregnant or breastfeeding or expecting to conceive children * has a history of immune suppression therapy ≤4 weeks prior to the screening day